The FDA has approved Tanzeum (albiglutide), from Glaxo Smith Kline, for injection, for subcutaneous use, as a once-weekly treatment for...
New data from secondary analyses of four randomised Phase III studies show that Type 2 Diabetes patients enrolled in the...
New data from a completed Phase III trial show Trulicity (dulaglutide) solution for injection 1.5 mg, from Eli Lilly, plus...
With the number of people with Type 2 Diabetes (T2D) reaching more than 300 million worldwide and rising, new...